vs
Side-by-side financial comparison of MFA FINANCIAL, INC. (MFA) and NATIONAL RESEARCH CORP (NRC). Click either name above to swap in a different company.
MFA FINANCIAL, INC. is the larger business by last-quarter revenue ($55.5M vs $35.2M, roughly 1.6× NATIONAL RESEARCH CORP). On growth, MFA FINANCIAL, INC. posted the faster year-over-year revenue change (9.2% vs -4.6%). Over the past eight quarters, MFA FINANCIAL, INC.'s revenue compounded faster (7.7% CAGR vs -0.2%).
MFA Financial, Inc. is a U.S.-headquartered real estate investment trust (REIT) specializing in investing in and managing residential and commercial mortgage-backed securities, mortgage loans, and other real estate-related financial assets. It caters primarily to institutional and individual investors across the U.S., focusing on delivering stable risk-adjusted returns via rigorous asset screening and risk management frameworks.
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
MFA vs NRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.5M | $35.2M |
| Net Profit | — | $1.8M |
| Gross Margin | — | — |
| Operating Margin | 97.9% | 13.3% |
| Net Margin | — | 5.1% |
| Revenue YoY | 9.2% | -4.6% |
| Net Profit YoY | — | -72.6% |
| EPS (diluted) | $0.43 | $49.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.5M | $35.2M | ||
| Q3 25 | $56.8M | $34.6M | ||
| Q2 25 | $61.3M | $34.0M | ||
| Q1 25 | $57.5M | $33.6M | ||
| Q4 24 | $50.8M | $36.9M | ||
| Q3 24 | $50.6M | $35.8M | ||
| Q2 24 | $53.5M | $35.0M | ||
| Q1 24 | $47.8M | $35.3M |
| Q4 25 | — | $1.8M | ||
| Q3 25 | $48.1M | $4.1M | ||
| Q2 25 | $33.2M | $-106.0K | ||
| Q1 25 | $41.2M | $5.8M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | $48.2M | $5.7M | ||
| Q2 24 | $41.9M | $6.2M | ||
| Q1 24 | $23.2M | $6.4M |
| Q4 25 | 97.9% | 13.3% | ||
| Q3 25 | 84.5% | 22.4% | ||
| Q2 25 | 54.5% | 4.7% | ||
| Q1 25 | 70.0% | 25.6% | ||
| Q4 24 | 6.8% | 26.0% | ||
| Q3 24 | 98.2% | 22.3% | ||
| Q2 24 | 79.1% | 25.3% | ||
| Q1 24 | 50.7% | 24.8% |
| Q4 25 | — | 5.1% | ||
| Q3 25 | 84.7% | 11.9% | ||
| Q2 25 | 54.2% | -0.3% | ||
| Q1 25 | 71.6% | 17.2% | ||
| Q4 24 | — | 17.8% | ||
| Q3 24 | 95.2% | 15.9% | ||
| Q2 24 | 78.4% | 17.6% | ||
| Q1 24 | 48.5% | 18.0% |
| Q4 25 | $0.43 | $49.58 | ||
| Q3 25 | $0.35 | $0.18 | ||
| Q2 25 | $0.21 | $-0.01 | ||
| Q1 25 | $0.31 | $0.25 | ||
| Q4 24 | $-0.01 | $0.27 | ||
| Q3 24 | $0.37 | $0.24 | ||
| Q2 24 | $0.32 | $0.26 | ||
| Q1 24 | $0.14 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $213.2M | $4.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.8B | $14.0M |
| Total Assets | $13.0B | $134.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $213.2M | $4.1M | ||
| Q3 25 | $305.2M | $2.2M | ||
| Q2 25 | $275.7M | $5.3M | ||
| Q1 25 | $253.7M | $2.5M | ||
| Q4 24 | $338.9M | $4.2M | ||
| Q3 24 | $305.6M | $3.5M | ||
| Q2 24 | $289.4M | $485.0K | ||
| Q1 24 | $306.3M | $1.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $48.7M | ||
| Q2 24 | — | $33.3M | ||
| Q1 24 | — | $35.2M |
| Q4 25 | $1.8B | $14.0M | ||
| Q3 25 | $1.8B | $14.3M | ||
| Q2 25 | $1.8B | $21.3M | ||
| Q1 25 | $1.8B | $29.7M | ||
| Q4 24 | $1.8B | $31.3M | ||
| Q3 24 | $1.9B | $34.6M | ||
| Q2 24 | $1.9B | $40.2M | ||
| Q1 24 | $1.9B | $36.9M |
| Q4 25 | $13.0B | $134.9M | ||
| Q3 25 | $12.1B | $135.7M | ||
| Q2 25 | $11.7B | $141.4M | ||
| Q1 25 | $11.5B | $135.2M | ||
| Q4 24 | $11.4B | $132.5M | ||
| Q3 24 | $11.2B | $131.8M | ||
| Q2 24 | $11.1B | $119.1M | ||
| Q1 24 | $10.9B | $120.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | 0.95× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $76.2M | $7.2M |
| Free Cash FlowOCF − Capex | — | $6.1M |
| FCF MarginFCF / Revenue | — | 17.2% |
| Capex IntensityCapex / Revenue | — | 3.2% |
| Cash ConversionOCF / Net Profit | — | 3.99× |
| TTM Free Cash FlowTrailing 4 quarters | — | $15.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $76.2M | $7.2M | ||
| Q3 25 | $14.7M | $13.8M | ||
| Q2 25 | $38.5M | $-1.1M | ||
| Q1 25 | $-14.6M | $6.6M | ||
| Q4 24 | $200.1M | $6.4M | ||
| Q3 24 | $-11.3M | $9.4M | ||
| Q2 24 | $46.5M | $6.8M | ||
| Q1 24 | $53.5M | $12.0M |
| Q4 25 | — | $6.1M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | — | $-4.1M | ||
| Q1 25 | — | $3.7M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | — | $7.9M |
| Q4 25 | — | 17.2% | ||
| Q3 25 | — | 29.4% | ||
| Q2 25 | — | -12.2% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | 22.4% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | 8.8% | ||
| Q1 25 | — | 8.9% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 15.0% | ||
| Q1 24 | — | 11.7% |
| Q4 25 | — | 3.99× | ||
| Q3 25 | 0.31× | 3.34× | ||
| Q2 25 | 1.16× | — | ||
| Q1 25 | -0.35× | 1.15× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | -0.23× | 1.66× | ||
| Q2 24 | 1.11× | 1.10× | ||
| Q1 24 | 2.30× | 1.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
